A new approach to metastatic melanoma discovered

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

​Combining chemotherapy and BRAF oncogene inhibitors is a very effective strategy for fighting metastatic melanoma, the leading cause of death from skin cancer in the world.

Read more

CNIO researchers discover a new pathway to tackle follicular lymphoma

by CNIO - Centro Nacional de Investigaciones Oncológicas

​Alejo Efeyan's team at the CNIO has shown in animal models that blocking signals controlled by the RagC protein delays the onset of follicular lymphoma without side effects

Read more

Cellular push and pull, a key to the body's response to processes such as cancer

by Fundació Clínic per a la Recerca Biomèdica

Researchers from IDIBAPS, IBEC, UB and CIBERES discover how force dynamics affect cells and living tissues. The results give an insight into the critical mechanical processes that occur in different d...

Read more

Reduced HIV reservoir through combination of antiretroviral therapy and the anticancer drug dasatinib

by IrsiCaixa

A study in which IrsiCaixa has participated shows that the anticancer drug dasatinib, in combination with antiretroviral treatment, reduces the reactivation ability and the size of the viral reservoir...

Read more

La exposición al VIH altera el nivel de biomarcadores inmunitarios en niños, aunque no desarrollen la infección

by CIBERESP - Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública

​La simple exposición al VIH, sin necesidad que se produzca infección por el virus, altera el nivel de algunos biomarcadores inmunitarios en niños. Así lo demuestra un estudio desarrollado por i...

Read more

PNAS. CNIO researchers clarify the role of the two isoforms of KRAS, the most common oncogene in human cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

KRAS was one of the first oncogenes to be identified, a few decades ago. It is among the most common drivers of cancer and its mutations can be detected in around 25 per cent of human tumours. The dev...

Read more

​ To die or not to die in response to stress, a decision regulated by MK2 protein levels

by IRB Barcelona - Instituto de Investigación Biomédica

Researchers at IRB Barcelona unveil a pathway that determines the fate of cells in response to stress conditions and identify an important mechanism that recovers cell balance.

Read more

Un proyecto sobre inmunoterapia del IDIBAPS, seleccionado en la convocatoria CaixaResearch de Investigación en Salud 2021

by Fundació Clínic per a la Recerca Biomèdica

Liderado por la investigadora Sònia Guedan, el proyecto se basa en el desarrollo de la inmunoterapia para atacar los tumores sólidos

Read more

EL CNIO recibe apoyo de la Fundación 'la Caixa' para estudiar la obesidad y algunos de los tumores más frecuentes

by CNIO - Centro Nacional de Investigaciones Oncológicas

Gracias al apoyo de la Fundación, Alejo Efeyan liderará el proyecto NUTRITHELIUM, que busca el origen de las patologías asociadas a la obesidad y cómo combatirlas Dotado con cerca de 1

Read more

Eight CSIC biomedical projects receive 6.5 million euros from the CaixaResearch aid program

by CSIC - Centro Superior de Investigaciones Científicas

Eight researches led by or with the participation of scientists from the Spanish National Research Council (CSIC) have been selected by the “la Caixa” Foundation among the 30 projects of the Caixa...

Read more

Scientists from the ibs.GRANADA show that the risk of developing acute myeloid leukemia depends on the presence of genetic variations in genes of the immune system

by Instituto de Investigación Biosanitaria - Ibs Granada

The Genetics of Malignant Hemopathies research group at ibs.GRANADA has shown that certain variations in genes of the immune system influence the risk of developing acute myeloid leukemia. These alter...

Read more

IDIBELL and ICO participate in the discovery of a weakness that could be used to treat defective cancers for SMARCA4

by Hospital Universitari de Bellvitge

The study suggests that tumors with a genetically inactivated form of the chromatin remodeling protein SMARCA4 are highly sensitive to inhibitors of the KDM6 family of histone demethylases.

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream